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Abstracts / International Journal of Surgery 23 (2015) S15eS134S126pelvic recurrence 10.5%(n¼2), no distant metastasis. Final histology 17%
upstaged, 61% down-staged and 22% unchanged. Day time urinary in-
continence 0%, Nocturnal incontinence 27.7%, continent 72.3%, failure to
void and Intermittent self catheterisation 27.7%. Average neo-bladder ca-
pacity 700-1400mls.
Conclusion: Downward trend noted in ONB reconstruction. Postop blood
transfusion none ;hospital stay 10 days. Higher self-catheterisation (CISC)
rate in male patients, urinary continence and complications rate are
equally comparable to other published series.
0795: TRIAL WITHOUT CATHETER; ARE WE FAILING OUR PATIENTS?
A. Anwar*, J. Makanjuola, M. Ahmed. Princess Royal University Hospital, UK
Aim: Acute urinary retention (AUR) is the most common urological
emergency with an incidence of approximately 3/1,000 men per annum in
England. Long waiting time for appointment to trial without catheter
(TWOC) clinics causing wide range of complications affecting patient’s
quality of life and burdened the NHS. This study was conducted to evaluate
TWOC clinic services across the UK.
Methods: Data collected through validated questionnaire uploaded to
senior urology registrar group(SURG) website, via controlled access to a
national list of www.nhs.net e-mail addresses of health professionals,
telephonic feedback and direct contact in urology meetings.
Results: TWOC available in 100% district hospitals. Urology nurse practi-
tioners(89.4%) doctors(5.3%) and healthcare assistants(5.3%) conducts the
clinics. 47% clinics scheduled twice per week. Average appointment time is
7-14days(55%). Prior to TWOC selective alpha-blocker prescribed in 92%.
Appointments booked through Urologist are 42%,(GP)10% and (A&E)40%.
71% patients spent 2-4 hrs and 13% spent>4hrs in TWOC clinics. 55.5%
clinics record ﬂow rate and residual urine. Only 26% departments do
regularaudits. 76% responders are satisﬁed from TWOC services others not
because of long waiting time.
Conclusion: The results high-lightened the risk associated aspects of the
care provision. It also raises the concerns about the quality of service and
areas of potential improvement.0802: ROLE OF IMAGING IN FOLLOW-UP AFTER RADICAL CYSTECTOMY
M. Chakravorty 1,*, M.S. Khan 2. 1University of Shefﬁeld, UK; 2Guys' and St
Thomas' NHS Foundation Trust, UK
Aim: We aim to devise an evidence-based up-to-date schedule for follow-
up imaging post-cystectomy for muscle-invasive bladder cancer: stratiﬁed
according to risk factors, recurrence timings, and relative survival beneﬁts
of early asymptomatic detection.
Methods: Medline and relevant EAU and AUA guidelines reference lists
were searched to identify appropriate papers for inclusion.
Results: CT and chest X-ray are best for detecting local and distant me-
tastases; MRI is a sensitive, non-ionising alternative. Trans-rectal ultraso-
nography may be effective in local recurrence detection.
80-90% of recurrences occur within three years: high stage and grade of
the primary tumour, and positive invasion status at cystectomy increase
risk. Local (pelvic) and distant (bone, liver and lung) metastases are more
likely to recur within the ﬁrst year, especially in high-risk groups. Early
detection is associated with longer survival times. After three years, uro-
thelial tumours are more likely to recur; however, there are no signiﬁcant
survival beneﬁts to routine imaging.
Conclusion: We propose three strata of patients: high risk (high grade/
stage), intermediate, or low. In the ﬁrst three years: high-risk patients
should be imaged 6-monthly; low-risk, annually; and patients with in-
termediate-risk, 6-monthly in the ﬁrst year, then annually. After three
years, imaging should be guided based on symptoms.
0804: ARE WE REQUESTING BONE SCANS APPROPRIATELY?
M. Pereira*, I. Ward, M.I. Johnson. Freeman Hospital, UK
Aim: To correlate the results of prostate cancer patient’s bone scans (BS)
with their PSA and pathology ﬁndings.Methods: A retrospective study of all BS performed between April and June
atourhospital, inpatients known tohave prostate cancer. The following data
was collected: age, BS reports, latest PSA, Gleason score and further imaging.
Results: During this period, 247 BS were performed. From these 167 BS
were performed for patients with prostate cancer. There were 141 patients
that were not known to have bone metastasis. In this group 19% had PSA
<10, and 26% had PSA 10-20. 19% of these BS were equivocal and required
further imaging, but after additional imaging were negative.
Overall no patient with PSA <20 had bone metastasis conﬁrmed, and also
25% of BS were positive e all of which had PSA >20. The likelihood for the
patient to have metastatic bone disease with PSA <20 is very low. The
ﬁnding of equivocal scans requires further imaging, which adds cost for the
NHS and stress for the patient.
Conclusion: The PSAvalue is a valuable tool for prediction of positive bone
scan, and it can be used to rationalise requesting bone scan and avoid
patient distress.
0838: ROLE OF PATHOLOGICAL EXAMINATION OF VAS DEFERENS IN
VASECTOMY
P. Cleaveland*, A. Doyle, M. Badat, B. Zelhof. Lancashire Teaching Hospitals
Trust, UK
Aim: Vasectomy is the most reliable form of male contraception. Current
practice at Royal Preston Hospital is to send the vas for pathological ex-
amination to conﬁrm its excision. The European Association of Urology and
Royal College of Reproductive Medicine Guidelines state that there is no
need for routine pathologic examination of the vas. Success of the proce-
dure is conﬁrmed by semen analysis at 12 weeks.
Methods: All males who underwent vasectomy in the trust from January
to December 2013 were included in the audit. Case notes and electronic
records were reviewed. Parameters including demographics, surgical
technique, histology, semen analysis and complications were recorded.
Results: 61 vasectomies were performed. Mean age was 39.5. 70.5% were
done under local anaesthetic. Vas histology was performed in 85.2% with
only 3.3% showing incomplete excision. 2 patients underwent re-do va-
sectomy due to positive semen analysis. One of these had normal vas
histology and the other the vas wasn’t found.
Conclusion: Pathological examinationof thevasdeferensdoesnotcontribute
to determining whether a vasectomy has been successful. Semen analysis is
the optimal test. We recommend that pathological examination of the vas is
no longer performed in our trust which will save costs and resources.
0895: OUTCOMES OF AUGMENTATION CYSTOPLASTY
S. Husain*, J. Bechar, M. Belal. University Hospitals Birmingham NHS
Foundation Trust, UK
Aim: To review postoperative complications for Augmentation Cystoplasty
procedures carried out in the Trust and to evaluate the quality of life (QoL)
of these patients post procedure.
Methods: A retrospective case note review for procedures in the last 3
years (August 2011 to 2014). Data on basic patient demographics, indica-
tion for surgery, procedure performed and post-operative complications
evaluated against Clavien-Dindo Classiﬁcation and documented. QoL
assessed using validated measures: EQ-5D-5L Health questionnaire and
ICIQ-UI Incontinence questionnaire.
Results: In total, 15 patients were identiﬁed in the last 3 years. Indi-
cation for surgery: 7 congenital and 8 acquired causes. 8 cases had
additional Mitrofanoff procedure. Overall, 8 cases had Clavien 1 com-
plications, 5 cases had Clavien 2 complications and 2 cases had Clavien
3b complications. EQ-5D-5L Health questionnaire conducted found an
average Mobility score 2.625, Self-care score 1.875, Usual activity score
1.875, Pain/discomfort score 1.875 (Score Min 1, Max 5). Average
Global Health percentage 66.25%. Average ICIQ score ¼ 3.375 (Min 0,
Max 21).
Conclusion: Overall, complications following Augmentation Cystoplasty
were in keeping with other centres, based on current literature. Patients
largely expressed a good QoL, with minimal post-procedure incontinence
reported.
